Inhibition of leukotriene-B4 signalling-mediated host response to tuberculosis is a potential mode of adjunctive host-directed therapy

This study provides a new mode of TB treatment along with mechanistic insights which can be further explored in pre-clinical trials.PMID:38504502 | DOI:10.1111/imm.13781

Source: Immunology - March 20, 2024 Category: Allergy & Immunology Authors: Ushashi Banerjee Salik Miskat Borbora Madhura Guha Vikas Yadav V Sanjay Amit Singh Kithiganahalli Narayanaswamy Balaji Nagasuma Chandra Source Type: research